Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - dennis discher

1 Results Sort By:
Selective phagocytosis of human cancer cells as target for immunotherapy
Cell therapy based methods to reduce tumor growth by disrupting the CD47-SIRPα interaction and targeting cells for phagocytosis with antibodies. Problem: Current cancer treatments (i.e. radiation, chemotherapy, etc.) result in multiple serious side effects due to lack of treatment specificity. Cancer immunotherapies in development target...
Published: 1/31/2020   |   Inventor(s): Dennis Discher
Keywords(s):  
Category(s): Therapeutics & Vaccines